Agarwal Arjun's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed Sep 21, 2026
- Accession no.
- 0000907654-26-000102
- Filed
- Sep 21, 2026, 5:38 PM ET
- Trade date
- Sep 21, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $51.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Agarwal ArjunCIK 0002033974 | Officer (Senior Vice President, Finance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Common Stock | SSaleDisposed | −533 | $95.75 | −$51,034.75 | 14,219 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.